Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Stuart Walter Peltz. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Stuart Walter Peltz har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:PTCT / PTC Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | 54 903 |
US:HSAQ / Health Sciences Acquisitions Corp 2 | Director | 22 261 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Stuart Walter Peltz. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp OBIO / Orchestra BioMed Holdings, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i OBIO / Orchestra BioMed Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i OBIO / Orchestra BioMed Holdings, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp PTCT / PTC Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i OBIO / Orchestra BioMed Holdings, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i OBIO / Orchestra BioMed Holdings, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Stuart Walter Peltz som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −301 | 54 903 | −0,55 | 45,63 | −13 734 | 2 505 114 | |
2023-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −2 320 | 166 962 | −1,37 | 45,63 | −105 857 | 7 618 142 | |
2023-01-26 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −284 | 55 204 | −0,51 | 47,45 | −13 476 | 2 619 502 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −492 | 55 488 | −0,88 | 44,36 | −21 825 | 2 461 425 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 189 | 169 282 | −0,70 | 44,36 | −52 744 | 7 509 282 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −571 | 55 980 | −1,01 | 42,93 | −24 515 | 2 403 384 | |
2023-01-12 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 228 | 170 471 | −0,72 | 42,93 | −52 722 | 7 318 814 | |
2023-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −279 | 56 551 | −0,49 | 41,66 | −11 622 | 2 355 700 | |
2023-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 786 | 171 699 | −1,03 | 41,66 | −74 398 | 7 152 328 | |
2023-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 18 000 | 56 830 | 46,36 | ||||
2023-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 53 000 | 173 485 | 43,99 | ||||
2022-06-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −407 | 38 239 | −1,05 | 26,83 | −10 919 | 1 025 876 | |
2022-04-15 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −82 | 38 646 | −0,21 | 45,28 | −3 713 | 1 749 852 | |
2022-02-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −282 | 38 728 | −0,72 | 40,00 | −11 281 | 1 549 197 | |
2022-02-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 961 | 120 485 | −1,60 | 40,00 | −78 444 | 4 819 641 | |
2022-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −330 | 39 010 | −0,84 | 39,31 | −12 974 | 1 533 639 | |
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 63 000 | 63 000 | |||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 165 000 | 165 000 | |||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 16 800 | 39 340 | 74,53 | ||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −294 | 22 540 | −1,29 | 38,52 | −11 326 | 868 354 | |
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 44 000 | 122 446 | 56,09 | ||||
2022-01-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 869 | 78 446 | −2,33 | 38,52 | −72 003 | 3 022 132 | |
2022-01-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −378 | 22 834 | −1,63 | 41,16 | −15 559 | 939 893 | |
2021-06-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 36 400 | 36 400 | |||||
2021-06-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 6 240 | 22 721 | 37,86 | ||||
2021-04-15 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 1 400 | 16 481 | 9,28 | ||||
2021-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −283 | 15 081 | −1,84 | 56,96 | −16 119 | 858 953 | |
2021-02-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 968 | 80 315 | −2,39 | 56,96 | −112 089 | 4 574 421 | |
2021-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −350 | 15 364 | −2,23 | 62,05 | −21 719 | 953 398 | |
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 23 100 | 23 100 | |||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 161 000 | 161 000 | |||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 3 960 | 15 714 | 33,69 | ||||
2021-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 27 600 | 82 283 | 50,47 | ||||
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −382 | 11 754 | −3,15 | 62,37 | −23 825 | 733 097 | |
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −284 | 12 136 | −2,29 | 62,37 | −17 713 | 756 922 | |
2021-01-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 402 | 54 683 | −2,50 | 62,37 | −87 443 | 3 410 579 | |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −115 937 | 149 063 | −43,75 | 33,02 | −3 828 240 | 4 922 060 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −169 781 | 5 219 | −97,02 | 30,86 | −5 239 442 | 161 058 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 938 | 56 085 | −12,40 | 63,25 | −502 047 | 3 547 152 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −30 060 | 64 023 | −31,95 | 62,27 | −1 871 776 | 3 986 584 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −77 939 | 94 083 | −45,31 | 61,43 | −4 787 793 | 5 779 519 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 115 937 | 172 022 | 206,72 | 33,02 | 3 828 240 | 5 680 166 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 212 | 56 085 | −12,77 | 63,19 | −518 924 | 3 544 067 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −38 779 | 64 297 | −37,62 | 62,34 | −2 417 560 | 4 008 404 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −122 790 | 103 076 | −54,36 | 61,43 | −7 543 358 | 6 332 268 |
2020-12-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 169 781 | 225 866 | 302,72 | 30,86 | 5 239 442 | 6 970 225 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −137 500 | 62 500 | −68,75 | 18,01 | −2 476 375 | 1 125 625 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −18 125 | 7 875 | −69,71 | 11,23 | −203 544 | 88 436 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −192 792 | 0 | −100,00 | 27,05 | −5 215 024 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −310 | 56 085 | −0,55 | 65,70 | −20 369 | 3 685 065 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 530 | 56 395 | −19,35 | 64,61 | −874 133 | 3 643 512 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 520 | 69 925 | −7,32 | 63,65 | −351 359 | 4 450 866 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 927 | 75 445 | −11,63 | 62,41 | −619 574 | 4 708 749 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −23 543 | 85 372 | −21,62 | 61,68 | −1 452 038 | 5 265 403 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 902 | 108 915 | −17,37 | 60,66 | −1 389 281 | 6 607 002 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −61 768 | 131 817 | −31,91 | 59,56 | −3 678 902 | 7 851 021 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 137 500 | 193 585 | 245,16 | 18,01 | 2 476 375 | 3 486 466 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −300 | 56 085 | −0,53 | 65,19 | −19 558 | 3 656 349 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 242 | 56 385 | −5,44 | 64,36 | −208 665 | 3 629 108 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −747 | 59 627 | −1,24 | 63,01 | −47 068 | 3 757 097 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 852 | 60 374 | −4,51 | 61,90 | −176 547 | 3 737 332 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 332 | 63 226 | −5,01 | 60,84 | −202 726 | 3 846 796 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 652 | 66 558 | −10,31 | 59,58 | −455 906 | 3 965 526 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 18 125 | 74 210 | 32,32 | 11,23 | 203 544 | 833 378 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 700 | 56 085 | −2,94 | 65,78 | −111 818 | 3 688 991 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 022 | 57 785 | −23,77 | 64,62 | −1 164 672 | 3 734 356 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 494 | 75 807 | −7,89 | 63,67 | −413 499 | 4 826 935 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 984 | 82 301 | −14,52 | 62,44 | −873 091 | 5 138 463 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −33 443 | 96 285 | −25,78 | 61,68 | −2 062 764 | 5 938 859 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −34 036 | 129 728 | −20,78 | 60,64 | −2 063 807 | 7 866 187 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −85 113 | 163 764 | −34,20 | 59,56 | −5 068 990 | 9 753 129 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 192 792 | 248 877 | 343,75 | 27,05 | 5 215 024 | 6 732 123 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −7 208 | 192 792 | −3,60 | 27,05 | −194 976 | 5 215 024 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −3 104 | 0 | −100,00 | 10,85 | −33 678 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −2 115 | 0 | −100,00 | 10,85 | −22 948 | |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 590 | 3 104 | −70,97 | 10,85 | −82 352 | 33 678 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −700 | 56 085 | −1,23 | 64,82 | −45 374 | 3 635 430 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 56 785 | −2,07 | 64,16 | −76 992 | 3 643 326 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 57 985 | −0,17 | 62,46 | −6 246 | 3 622 033 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 300 | 58 085 | −2,19 | 61,83 | −80 375 | 3 591 221 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 100 | 59 385 | −1,82 | 60,72 | −66 796 | 3 606 095 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 808 | 60 485 | −4,44 | 59,56 | −167 259 | 3 602 789 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 208 | 63 293 | 12,85 | 27,05 | 194 976 | 1 712 076 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −300 | 56 085 | −0,53 | 64,71 | −19 412 | 3 629 092 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 56 385 | −0,88 | 64,01 | −32 005 | 3 609 204 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −449 | 56 885 | −0,78 | 61,88 | −27 782 | 3 519 759 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −600 | 57 334 | −1,04 | 60,95 | −36 569 | 3 494 393 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 255 | 57 934 | −2,12 | 59,52 | −74 694 | 3 448 058 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 104 | 59 189 | 5,53 | 10,85 | 33 678 | 642 201 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 56 085 | −0,88 | 64,42 | −32 210 | 3 612 996 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 56 585 | −0,70 | 61,88 | −24 754 | 3 501 763 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 56 985 | −0,70 | 60,68 | −24 272 | 3 457 907 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −815 | 57 385 | −1,40 | 59,52 | −48 505 | 3 415 268 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 115 | 58 200 | 3,77 | 10,85 | 22 948 | 631 470 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −100 | 56 085 | −0,18 | 65,12 | −6 512 | 3 652 255 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 600 | 56 185 | −2,77 | 64,41 | −103 051 | 3 618 707 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 57 785 | −0,69 | 63,21 | −25 284 | 3 652 590 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 58 185 | −2,02 | 61,93 | −74 312 | 3 603 222 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 200 | 59 385 | −1,98 | 60,87 | −73 042 | 3 614 646 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 090 | 60 585 | −4,85 | 59,56 | −184 037 | 3 608 382 |
2020-12-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 590 | 63 675 | 13,53 | 10,85 | 82 352 | 690 874 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −8 421 | 18 529 | −31,25 | 33,02 | −278 061 | 611 828 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 065 | 13 399 | −34,52 | 18,01 | −127 241 | 241 316 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −2 362 | 2 363 | −49,99 | 11,23 | −26 525 | 26 536 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −7 560 | 0 | −100,00 | 30,86 | −233 302 | |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −2 505 | 20 464 | −10,91 | 18,01 | −45 115 | 368 557 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −1 575 | 4 725 | −25,00 | 11,23 | −17 687 | 53 062 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −500 | 375 | −57,14 | 12,64 | −6 320 | 4 740 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −3 440 | 7 560 | −31,27 | 30,86 | −106 158 | 233 302 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −4 900 | 0 | −100,00 | 27,05 | −132 545 | |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −8 421 | 12 178 | −40,88 | 60,00 | −505 260 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 8 421 | 20 599 | 69,15 | 33,02 | 278 061 | 680 179 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 065 | 12 178 | −36,71 | 60,00 | −423 900 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 065 | 19 243 | 58,01 | 18,01 | 127 241 | 346 566 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 362 | 12 178 | −16,24 | 60,00 | −141 720 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 362 | 14 540 | 19,40 | 11,23 | 26 525 | 163 284 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 560 | 12 178 | −38,30 | 60,00 | −453 600 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 560 | 19 738 | 62,08 | 30,86 | 233 302 | 609 115 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 505 | 12 178 | −17,06 | 60,00 | −150 300 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 2 505 | 14 683 | 20,57 | 18,01 | 45 115 | 264 441 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 575 | 12 178 | −11,45 | 60,00 | −94 500 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 575 | 13 753 | 12,93 | 11,23 | 17 687 | 154 446 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −500 | 12 178 | −3,94 | 60,00 | −30 000 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 500 | 12 678 | 4,11 | 12,64 | 6 320 | 160 250 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 440 | 12 178 | −22,03 | 60,00 | −206 400 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 440 | 15 618 | 28,25 | 30,86 | 106 158 | 481 971 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 900 | 12 178 | −28,69 | 60,00 | −294 000 | 730 680 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 4 900 | 17 078 | 40,24 | 27,05 | 132 545 | 461 960 |
2020-11-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 037 | 12 178 | −47,54 | 60,00 | −662 220 | 730 680 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −50 000 | 2 115 | −95,94 | 10,85 | −542 500 | 22 948 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 813 | 56 085 | −17,40 | 54,79 | −647 282 | 3 073 121 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 114 | 67 898 | −11,83 | 53,86 | −490 907 | 3 657 190 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −29 073 | 77 012 | −27,41 | 53,13 | −1 544 765 | 4 091 956 |
2020-11-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −48 175 | 26 000 | −64,95 | 11,23 | −541 005 | 291 980 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −22 929 | 10 694 | −68,19 | 10,85 | −248 780 | 116 030 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −31 681 | 56 085 | −36,10 | 53,62 | −1 698 608 | 3 007 053 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 494 | 87 766 | −15,82 | 52,94 | −873 126 | 4 645 981 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 48 175 | 104 260 | 85,90 | 11,23 | 541 005 | 1 170 840 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 786 | 56 085 | −17,37 | 53,69 | −632 814 | 3 011 316 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 143 | 67 871 | −14,10 | 53,01 | −590 713 | 3 597 977 |
2020-10-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 22 929 | 79 014 | 40,88 | 10,85 | 248 780 | 857 302 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −51 825 | 74 175 | −41,13 | 11,23 | −581 995 | 832 985 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −22 511 | 33 623 | −40,10 | 10,85 | −244 244 | 364 810 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −50 015 | 52 115 | −48,97 | 10,85 | −542 663 | 565 448 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −51 825 | 56 085 | −48,03 | 50,14 | −2 598 350 | 2 811 934 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 51 825 | 107 910 | 92,40 | 11,23 | 581 995 | 1 211 829 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 511 | 56 085 | −28,64 | 50,15 | −1 128 882 | 2 812 551 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 22 511 | 78 596 | 40,14 | 10,85 | 244 244 | 852 767 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −50 015 | 56 085 | −47,14 | 50,10 | −2 505 852 | 2 809 971 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 015 | 106 100 | 89,18 | 10,85 | 542 663 | 1 151 185 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −54 560 | 56 134 | −49,29 | 10,85 | −591 976 | 609 054 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −900 | 102 130 | −0,87 | 10,85 | −9 765 | 1 108 110 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −54 560 | 56 085 | −49,31 | 50,00 | −2 728 000 | 2 804 250 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 54 560 | 110 645 | 97,28 | 10,85 | 591 976 | 1 200 498 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −900 | 56 085 | −1,58 | 50,00 | −45 000 | 2 804 250 |
2020-10-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 900 | 56 985 | 1,60 | 10,85 | 9 765 | 618 287 |
2020-08-10 | 3/A | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
22 261 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-08-03 | 3 | HSAQ |
Health Sciences Acquisitions Corp 2
Ordinary Shares |
40 522 | ||||||||
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −50 000 | 103 030 | −32,67 | 10,85 | −542 500 | 1 117 876 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −50 000 | 103 030 | −32,67 | 10,85 | −542 500 | 1 117 876 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 401 | 56 085 | −30,32 | 55,93 | −1 364 748 | 3 136 834 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −25 599 | 80 486 | −24,13 | 55,48 | −1 420 233 | 4 465 363 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 50 000 | 106 085 | 89,15 | 10,85 | 542 500 | 1 151 022 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 403 | 56 085 | −30,32 | 55,94 | −1 365 177 | 3 137 563 |
2020-07-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −25 597 | 80 488 | −24,13 | 55,48 | −1 419 994 | 4 465 072 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −33 788 | 203 030 | −14,27 | 10,85 | −366 600 | 2 202 876 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −33 788 | 56 085 | −37,60 | 50,00 | −1 689 400 | 2 804 250 |
2020-05-22 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 33 788 | 89 873 | 60,24 | 10,85 | 366 600 | 975 122 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −6 284 | 236 818 | −2,58 | 10,85 | −68 181 | 2 569 475 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 284 | 56 085 | −10,08 | 50,12 | −314 979 | 2 811 205 |
2020-05-20 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 6 284 | 62 369 | 11,20 | 10,85 | 68 181 | 676 704 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −109 928 | 243 102 | −31,14 | 10,85 | −1 192 719 | 2 637 657 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 985 | 56 085 | −3,42 | 51,01 | −101 253 | 2 860 840 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −107 943 | 58 070 | −65,02 | 50,33 | −5 432 339 | 2 922 431 |
2020-05-07 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 109 928 | 166 013 | 196,00 | 10,85 | 1 192 719 | 1 801 241 |
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 28 600 | 28 600 | |||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 192 500 | 192 500 | |||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 4 855 | 22 957 | 26,82 | ||||
2020-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 33 000 | 56 085 | 142,95 | ||||
2020-01-27 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −423 | 18 102 | −2,28 | 53,25 | −22 523 | 963 877 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −359 | 18 525 | −1,90 | 48,17 | −17 292 | 892 312 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −439 | 18 884 | −2,27 | 48,17 | −21 146 | 909 605 | |
2020-01-08 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 797 | 23 085 | −7,22 | 48,17 | −86 558 | 1 111 958 | |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −7 656 | 22 969 | −25,00 | 18,01 | −137 885 | 413 672 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −5 741 | 6 300 | −47,68 | 11,23 | −64 471 | 70 749 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −1 000 | 875 | −53,33 | 12,64 | −12 640 | 11 060 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −559 | 12 041 | −4,44 | 11,23 | −6 278 | 135 220 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −125 | 1 875 | −6,25 | 12,64 | −1 580 | 23 700 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
M - Exercise | X | −3 900 | 0 | −100,00 | 10,85 | −42 315 | |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 656 | 18 676 | −29,07 | 50,00 | −382 800 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 7 656 | 26 332 | 40,99 | 18,01 | 137 885 | 474 239 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 741 | 18 676 | −23,51 | 50,00 | −287 050 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 5 741 | 24 417 | 30,74 | 11,23 | 64 471 | 274 203 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 000 | 18 676 | −5,08 | 50,00 | −50 000 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 1 000 | 19 676 | 5,35 | 12,64 | 12 640 | 248 705 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −559 | 18 676 | −2,91 | 50,00 | −27 950 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 559 | 19 235 | 2,99 | 11,23 | 6 278 | 216 009 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −125 | 18 676 | −0,66 | 50,00 | −6 250 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 125 | 18 801 | 0,67 | 12,64 | 1 580 | 237 645 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 900 | 18 676 | −17,27 | 50,00 | −195 000 | 933 800 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 3 900 | 22 576 | 20,88 | 10,85 | 42 315 | 244 950 |
2019-12-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 482 | 18 676 | −15,71 | 50,00 | −174 100 | 933 800 |
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 26 950 | 26 950 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 55 000 | 55 000 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
A - Award | 265 000 | 265 000 | |||||
2019-01-24 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 4 620 | 22 158 | 26,34 | ||||
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −409 | 17 538 | −2,28 | 34,75 | −14 213 | 609 446 | |
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −339 | 17 947 | −1,85 | 34,75 | −11 780 | 623 658 | |
2019-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 764 | 24 882 | −6,62 | 34,75 | −61 299 | 864 650 | |
2018-01-09 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | −2 230 | 26 646 | −7,72 | 18,03 | −40 207 | 480 427 | |
2018-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 200 000 | 200 000 | |||||
2017-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right To Buy) |
A - Award | 126 000 | 126 000 | |||||
2017-01-05 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
A - Award | 21 600 | 28 876 | 296,87 | ||||
2016-01-06 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 175 000 | 175 000 | |||||
2015-06-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | −3 500 | 353 030 | −0,98 | ||||
2015-06-17 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 500 | 7 276 | 92,69 | 10,85 | 37 975 | 78 945 | |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −26 300 | 356 530 | −6,87 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 3 776 | −9,58 | 54,29 | −21 716 | 204 999 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −13 400 | 4 176 | −76,24 | 53,64 | −718 776 | 224 001 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 500 | 17 576 | −41,56 | 52,89 | −661 125 | 929 595 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 26 300 | 30 076 | 696,50 | 10,85 | 285 355 | 326 325 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −17 170 | 382 830 | −4,29 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (Right to Buy) |
M - Exercise | X | −60 306 | 110 694 | −35,27 | |||
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 500 | 3 776 | −48,10 | 56,40 | −197 400 | 212 966 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −22 300 | 7 276 | −75,40 | 55,71 | −1 242 333 | 405 346 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −36 075 | 29 576 | −54,95 | 54,64 | −1 971 138 | 1 616 033 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 825 | 65 651 | −15,26 | 53,81 | −636 303 | 3 532 680 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 17 170 | 77 476 | 28,47 | 10,85 | 186 294 | 840 615 |
2015-06-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
M - Exercise | X | 60 306 | 60 306 | 10,85 | 654 320 | 654 320 | |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −1 900 | 0 | −100,00 | 70,57 | −134 083 | |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 575 | 1 900 | −77,58 | 69,79 | −458 869 | 132 601 |
2015-03-23 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −38 725 | 8 475 | −82,04 | 68,96 | −2 670 476 | 584 436 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −400 | 47 200 | −0,84 | 72,27 | −28 908 | 3 411 144 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 200 | 47 600 | −6,30 | 71,48 | −228 736 | 3 402 448 |
2015-03-11 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −43 601 | 50 800 | −46,19 | 70,67 | −3 081 283 | 3 590 036 |
2015-01-02 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 300 000 | 300 000 | 51,00 | 15 300 000 | 15 300 000 | ||
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 980 | 94 401 | −3,06 | 43,89 | −130 792 | 4 143 260 |
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −18 621 | 97 381 | −16,05 | 43,06 | −801 820 | 4 193 226 |
2014-10-03 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −19 900 | 116 002 | −14,64 | 42,09 | −837 591 | 4 882 524 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 714 | 135 902 | −4,03 | 30,73 | −175 591 | 4 176 268 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 600 | 141 616 | −6,96 | 30,10 | −319 060 | 4 262 642 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −9 022 | 152 216 | −5,60 | 29,08 | −262 360 | 4 426 441 |
2014-03-25 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −151 | 161 238 | −0,09 | 27,39 | −4 136 | 4 416 309 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −174 | 161 389 | −0,11 | 32,76 | −5 700 | 5 287 104 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −988 | 161 563 | −0,61 | 31,81 | −31 428 | 5 139 319 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 816 | 162 551 | −2,29 | 30,80 | −117 533 | 5 006 571 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 854 | 166 367 | −8,70 | 30,00 | −475 620 | 4 991 010 |
2014-03-10 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −6 582 | 182 221 | −3,49 | 28,82 | −189 693 | 5 251 609 |
2014-01-31 |
|
4 | PTCT |
PTC THERAPEUTICS, INC.
Stock Option (right to buy) |
A - Award | 200 000 | 200 000 | 27,05 | 5 410 000 | 5 410 000 | ||
2013-06-19 | 3 | PTCT |
PTC THERAPEUTICS, INC.
Common Stock |
188 803 |